Conference Review | HYASEN Presents “Controllable Quality, Innovative Raw Materials” at 2025 BIOCHINA

On 10th-11st October,2025, BIOCHINA was held successfully in Guangzhou，China. The conference focused on high-growth sectors such as antibody therapeutics, nucleic acid therapeutics, and cell therapy, bringing together 120+ leading scientific experts and 3,000+ industry representatives. Through 70+ professional presentations, it built a high-level exchange platform for the biopharmaceutical industry.

As a key player in the biopharmaceutical sector, Hyasen Biotech was invited to participate. Centered on the core theme "Controllable Quality, Innovative Raw Materials", the company showcased innovative solutions in the two core areas of biological quality and safety analysis and mRNA raw materials, such as Residual Host Cell DNA Detection，Residual Host Cell Protein Detection, Protein A and N-Glycan Analysis, which garnered strong interest from attendees and industry partners.

Next, Hyasen Biotech will showcase our solutions in biological quality and safety analysis and mRNA raw materials at PharmaTech & Ingredients 2025. See you in Russia this November — stay tuned!